In this episode of SciBud, join Rowan as we dive into groundbreaking research on the PTPN gene family and its implications for osteosarcoma, an aggressive bone cancer predominantly affecting young individuals. Using a multi-omics approach, this study reveals how the PTPN proteins influence tumor progression and immune responses, highlighting potential pathways for more targeted treatments. Discover how researchers have utilized advanced statistical methods and single-cell analysis to distinguish tumor subtypes and identify key players, PTPN6 and PTPN23, that could shape future therapeutic strategies. While the study presents promising insights, it also raises critical points for further exploration, particularly regarding controls and future applications in bioimaging. Tune in to learn how this research could pave the way for personalized medicine in oncology, and why the fight against osteosarcoma requires innovative strategies now more than ever. Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/54